Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis
- 19 January 2018
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 10 (10), 942-948
- https://doi.org/10.1136/neurintsurg-2017-013632
Abstract
Background This meta-analysis aimed to evaluate the association between antiplatelet resistance and the risk of procedure-related complications in neurovascular interventions. Methods We identified relevant articles by searching electronic databases and reviewed the reference lists of selected papers. The risk of adverse events between antiplatelet responders and hyporesponders during neurointervention was compared in eligible clinical studies. Risk ratios (RRs) and 95% CIs were pooled using a random-effects meta-analysis. Results Of 2134 potentially relevant studies, our search identified 15 studies enrolling a total of 2365 patients. Pooled RRs showed thromboembolic events (TEE) were more frequent in hyporesponders (RR 2.634, 95% CI 1.465 to 4.734). However, hemorrhagic complications did not differ between the two groups (RR 1.236, 95% CI 0.642 to 2.380). In subgroup analysis, hyporesponders showed a higher prevalence of TEE with standard antiplatelet medication, but there was no obvious difference in TEE between the two arms when using a modified antiplatelet medication (RR 3.645, 95% CI 1.537 to 8.646; and RR 1.877, 95% CI 0.749 to 4.751). Studies using stent placement for aneurysms showed a higher TEE rate in hyporesponders (RR 3.221, 95% CI 1.899 to 5.464). Conclusion Antiplatelet resistance was significantly associated with TEE in neurointervention, and this adverse event was associated with individually-intensified antiplatelet medication as well as the type of neurointerventional procedure. Our findings support the use of antiplatelet resistance assays and tailored antiplatelet medications in neurovascular stent placement as a management strategy to reduce thromboembolic risk.Keywords
Funding Information
- Kyung Hee University
This publication has 30 references indexed in Scilit:
- Platelet function testing: does a randomized controlled trial settle the debate?Journal of NeuroInterventional Surgery, 2015
- Antiplatelet testing in neurointervention: we cannot ignore the signsJournal of NeuroInterventional Surgery, 2013
- Point of care platelet function testing in routine neurointerventional care is unjustifiedJournal of NeuroInterventional Surgery, 2013
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCIJAMA, 2010
- Thromboembolic Complications of Elective Coil Embolization of Unruptured AneurysmsNeurosurgery, 2010
- Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) StudyJournal of the American College of Cardiology, 2008
- Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysisBMJ, 2008
- Variability in Individual Responsiveness to Clopidogrel: Clinical Implications, Management, and Future PerspectivesJournal of the American College of Cardiology, 2007
- Antiplatelet Therapy in Neuroendovascular TherapeuticsNeurosurgery Clinics of North America, 2005
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000